Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CalciMedica Inc CALC

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.


NDAQ:CALC - Post by User

User Avatar Image
(11)
•••
  • alphaflightX
Post by alphaflighton Sep 23, 2021 9:41am
716 Views
Post# 33904269

Graycliff Expands Near Surface High-Grade Interval in Hole 9

Graycliff Expands Near Surface High-Grade Interval in Hole 9
Graycliff Exploration Expands Near Surface
High-Grade Interval in Hole 9 to
13.32 g/t Gold Over 16.0 Metres
TORONTO, ON – September 23, 2021 -  Graycliff Exploration Limited (the “Company” or “Graycliff”) (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) is pleased to announce expanded (full) assay results on the previously announced second drill hole of its over 2,000 metre (“m”) phase two core drilling program on the Company’s Shakespeare Gold Project located on the prolific Canadian Shield near Sudbury, Ontario.
 
Drill Hole J-9-21 intersected a mineralized interval of 13.32 g/t gold (“Au”) over 16.0 metres, including the previously announced interval of 52.0 g/t Au over 4.0 m (see Press Release dated June 15, 2021), as detailed below:
Table 1 - Highlighted Results from Hole J-9-21
 
President and CEO, James Macintosh stated: “The second hole of phase two drilling has returned a second extended intersection of mineralization with very strong gold grades throughout and provides further evidence that we are in one larger zone as mentioned when we announced the results of Hole J-8-21.  Hole J-9-21 also shows us that the higher-grade mineralized zone flanked by lower-grade mineralization that we would look to include in any potential mining scenario in the future. It is important to note that highest grade intersection in Hole J-9-21 is below the depth of the historic mine workings.”
 
Qualified Person
Bruce Durham, P.Geo, is a Qualified Person, as that term is defined by Canadian regulatory guidelines under NI 43-101, and has read and approved the technical information contained in this press release.
About Graycliff Exploration Limited.
Graycliff Exploration is a mineral exploration company focused on its 1,025 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of one crown patented lease, two crown leases and 40 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907. Graycliff’s Baldwin Project is adjacent to the east and is comprised of 68 claims covering 1,500 hectares. This brings our total land package in the area to 2,525 hectares.
For more information, contact investor relations at [email protected]
 
On Behalf of the Board of Directors,
 
James Macintosh
President and CEO
 

<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities